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Hereditary factors are suspected to contribute to the
pathogenesis of sporadic primary glomerulonephritis, but
their contribution is difficult to delineate in the general
population. We studied the prevalence of primary
glomerulonephritis in an isolated population from the
extreme northern Valtrompia valley, Northern Italy.
Investigation of medical records, community urinary
screening program and molecular characterization of the
population’s ancestry were performed; genealogies of
affected individuals were researched. Forty-three patients
with primary glomerulonephritis were identified: 25 had
biopsy-proven disease (11 immunoglobulin A (IgA)
nephropathy; eight mesangial proliferative
glomerulonephritis without IgA deposits; four focal
segmental glomerular sclerosis; two membranous
nephropathy), and 18 had clinical glomerulonephritis. All 43
patients originated from three mountain villages (Collio, San
Colombano, and Bovegno). In contrast, we found only four
cases of primary glomerulonephritis in two nearby villages
(Pezzaze and Tavernole) that shared similar population
histories and lifestyles, demonstrating heterogeneity of risk
factors for glomerulonephritis (P¼ 3 105). All 43 affected
individuals could be traced back to common ancestors
(XVI–XVII centuries), enabling the construction of three large
pedigree including three parent–child affected pairs and five
affected siblings pairs. Molecular data showed lower genetic
diversity and increased inbreeding in the Valtrompia
population compared to the control population. Molecular
and genealogical evidence of limited set of founders and the
absence of shared nephritogenic environmental factors
suggest that our patients share a common genetic
susceptibility to the development of primary
glomerulonephritis. Further molecular study of our families
will offer the possibility to shed light on the genetic
background underlying these glomerular disorders.
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Primary glomerulonephritis are heterogeneous disorders,
occurring as primary diseases or associated with systemic
illnesses or environmental exposures. Ethnic and geographic
variation in the prevalence of disease and reports of familial
cases have long indicated that hereditary factors play an
important pathogenetic role.1–5 Many studies have described
familial aggregation of IgA nephropathy (IgAN) in extended
kindreds.6–13 These pedigrees have enabled the execution of a
genome-wide linkage study in 30 IgAN families, leading to
the identification of the first IgAN locus on chromosome
six.14 Similarly, studies of familial forms of focal segmental
glomerulosclerosis (FSGS) have enabled significant insight
into disease pathogenesis.15
Although substantial success has been achieved in
outlining biological pathways involved in Mendelian sub-
types of glomerular disease, a large fraction of non-familial
disease remains unexplained. Multifactorial determination
has complicated the task of identifying specific genetic
components. In these settings, isolated populations offer
the opportunity to improve the resolution of genetic studies
of sporadic disease,16 because the low number of founders
and the reduced environmental variation reduces background
noise. Thus, genealogic studies of isolates can uncover close
familial relationship between ‘sporadic’ cases and identifica-
tion of shallow pedigrees that are tractable to linkage
analysis.17–19
Herein, we report the results of a clinical, genealogic, and
molecular study performed in a population isolate living in
Northern Italy, characterized by high frequency of primary
glomerulonephritis (Figure 1). Three extended pedigrees,
potentially related, including 43 cases of primary glomerulo-
nephritis were identified and investigated, in order to better
define the genetic contribution to the development of the
disease.
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RESULTS
Epidemiology of glomerulonephritis in northern Valtrompia
From 1971 to 1998, chart revealed that primary glomerulo-
nephritis was diagnosed in 39 patients. Thirty-five were
born in San Colombano (16 patients), Collio (six patients),
and Bovegno (13 patients); 18 patients had biopsy-proven
glomerulonephritis; and 17 clinical glomerulonephritis. Eight
affected family members were deceased at the time of the
study. The remaining four patients were born in Tavernole
(one clinical glomerulonephritis; one membranous nephro-
pathy) and Pezzaze (two clinical glomerulonephritis). During
1999, urine was tested from 5642 subjects (91% of
inhabitants of the five villages). The screening enabled us to
discover eight asymptomatic, previously undiagnosed, cases
of primary glomerulonephritis (seven biopsy-proven and one
clinical glomerulonephritis); three cases were discovered in
patients born in San Colombano (Pedigree no. 1: XII-15;
XIII-9; XI-33); two in patients born in Collio (Pedigree no. 2:
IX-1;VII-21); two in patients born in Bovegno (Pedigree no.
3: XII-1; XII-3); and one patient (Pedigree no. 3: X-31) born
in Pezzaze to an emigrant father born in Bovegno and
connected by kinship to Bovegno kindred.
Collio, San Colombano, and Bovegno
At the end of the study, we had identified 43 patients with
primary glomerulonephritis who originated from these three
villages in extreme northern Valtrompia: 25 had biopsy-
proven primary glomerulonephritis (11 IgAN; eight mesan-
gial proliferative glomerulonephritis without immunoglobulin
A (IgA) deposits; four FSGS; two membranous nephro-
pathy); and 18 had clinical glomerulonephritis. One patient
from San Colombano (Pedigree no. 1, XII-1) underwent
renal biopsy twice; initial renal biopsy showed no IgA
deposits; and the second renal biopsy, concomitant with a
new nephritic episode, showed diffuse mesangial IgA
deposits. Clinical, laboratory, and biopsy features of all
affected individuals are reported in Table 1.
In 1999, the prevalence of end-stage renal disease (ESRD)
(in extreme northern Valtrompia, calculated on a current
population of 4700 people, was 3.5-fold higher than among
Italian population: 2.776 cases per million of population
(p.m.p.) in extreme northern Valtrompia and 791 p.m.p. in
Italy.20 In 1999, we identified 35 living patients with primary
glomerulonephritis from this region (0.74%); thus, there was
one clinically recognized renal disease for every 135 members
of the extreme northern Valtrompia population (4700
inhabitants from Collio, San Colombano, and Bovegno).
The high ESRD prevalence observed in extreme northern
Valtrompia population was mainly attributable to a high rate
of primary glomerulonephritis, which account for 61.5% of
cases of ESRD (in comparison to 24.9% in Italy and to 31.5%
in Lombardy, the Italian region in which the district of
Brescia is located).21
Pezzaze and Tavernole
In contrast, in the population of the two nearby villages,
Pezzaze and Tavernole, only one new case of primary
glomerulonephritis was identified. Remarkably, this patient
was born in Pezzaze to an emigrant father born in Bovegno.
Finally, in 1999, only two cases of ESRD (owing to diabetic
nephropathy and polycystic kidney disease) were found in
Pezzaze and one case in Tavernole (owing to obstructive
nephropathy).
This marked skewness in the prevalence of primary
glomerulonephritis in the five villages was highly statistically
significant (w2, P¼ 3 105). This variation in disease
prevalence in different villages strongly suggests heterogene-
ity in risk factors for glomerulonephritis. We therefore
searched for environmental risk factors, but our epidemio-
logical investigation failed to reveal any nephritogenic factors.
No data supported an occupational nature of glomerulo-
nephritis. Diet was the usual diet of Italian alpine valleys
(cereals, diary products, farmyard animal meat). An obvious
common environmental trigger, such as viral or streptococcal
epidemic, was not identified. Hence, we next searched the
genealogy of the villages with high incidence to investigate
the role of hereditary factors in the determination of disease.
Genealogic investigation
Extensive genealogic research, focused only on the three
villages with high prevalence of glomerulonephritis (San
Colombano, Collio, Bovegno), allowed us to reconstruct the
genealogy of all affected family members. Ancestors of our
patients all originated in the Valtrompia region and were
natives of the same village from which patients were
ascertained. Marriage records showed that exogamy was
low. Some close cousins did marry and unsuspected kinship
between spouses was discovered. Predictably, some indivi-
duals were related to more than one member of the same pedi-
gree. Several marriages between villagers of San Colombano,
Valtrompia Valley
Italy
Val Saviore 
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Figure 1 | Map of the Valtrompia valley showing the five isolated
mountain villages where the study was carried out.
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Collio, and Bovegno were documented, confirming strong
kinship between the three pedigrees. Remarkably, we were
able to reconstruct three extended kindreds connecting
affected individuals ascertained from each village to a single
common ancestor also originating from that same village.
Pedigree no. 1 (Figure 2). Pedigree no. 1 included 22
patients, connected by kinship to one large pedigree (14
generations) with common ancestors from 1570: 19 were
native of San Colombano; one (XI-15) was born in Bovegno
to an emigrant mother; and two (XI-38, XII-22) were born in
Collio, but were also included in Pedigree no. 1 because their
great-grand mother were native of San Colombano. The kin-
dred included six IgAN; six with mesangial proliferative GN
without IgA deposits; two with membranous nephropathy;
Table 1 | Clinical and histological data of affected family members of the three villages
Pedigree no. Diagnosis
Renal biopsy:
immunofluorescence
Age at
diagnosis/sex Clinical onset
SCr (mg/dl) at
diagnosis/
follow-up
Follow-up
(years)
San Colombano, Pedigree no. 1
1 IX-23 Clinical GN ND ND/M / / /
2 XI-15 Clinical GN ND 45/M MH, prot 3.0/TX 20
3 XI-20 Clinical GN ND 63/M mH, prot 1.4/1.1 13
4 XI-21 Clinical GN ND 52/M mH, prot 1.5/HD 2
5 XI-37 Clinical GN ND 75/F mH, prot 5.0/PD 6
6 XII-28 Clinical GN ND 40/F mH, prot 2.0/TX 17
7 XI-35 Clinical GN ND 40/M mH, prot 2.5/TX 15
8 XIII-17 Clinical GN ND 57/M mH, prot 1.2/2.8 5
9 XI-38a IgAN IgA 50/M mH, prot 2.0/HD 15
10 XIII-4 IgAN IgA 35/M MH 1.1/1.0 15
11 XII-1 IgAN IgA, C3 50/M mH, prot 1.2/1.4 8
12 XIV-1 IgAN IgA, IgM, C3 19/M MH 2.0/1.6 5
13 XIII-6 IgAN IgA 25/M MH 1.1/1.0 20
14 XI-18 IgAN IgA 50/M mH, prot 1.6/HD 20
15 XII-22a Mes. Prol. GN C3 50/M mH, prot 1.6/6.0 10
16 XII-34 Mes. Prol. GN IgM, IgG, C3 21/F mH 0.8/0.8 4
17 XII-15 Mes. Prol. GN IgM 45/M prot 1.1/1.0 10
18 XI-46 Mes. Prol. GN IgM IgG C3 60/M MH 2.0/HD 10
19 XI-33 Mes. Prol. GN C3 77/F mH 0.9/0.9 4
20 XIII-14 Mes. Prol. GN IgM C3 42/M prot 1.1/1.3 9
21 XIII-9 Membranous N IgG C3 40/M N S 1.0/1.1 13
22 XII-25 Membranous N IgG C3 35/M N S 1.0/1.0 10
Collio, Pedigree no. 2
1 VIII-1 Clinical GN ND 60/M mH, prot 2.0/HD 10
2 VIII-8 Clinical GN ND 70/M mH,prot 1.2/1.2 10
3 VIII-21 Clinical GN ND 64/M mH, prot 1.2/1.2 4
4 VIII-25 Clinical GN ND 50/M mH, prot 5.0/HD 15
5 VIII-15a IgAN IgA 50/M mH, prot 2.0/HD 15
6 IX-1 IgAN IgA, IgM IgG, C3 40/M mH, prot 1.0/1.0 13
7 VIII-12a Mes. Prol. GN C3 50/M mH, prot 1.6/6.0 10
8 IX-18 FSGS IgM C3 40/F NS 1.3/PD 13
Bovegno, Pedigree no. 3
1 X-7 Clinical GN ND 42/F mH, prot 3/TX 17
2 X-10 Clinical GN ND 45/M mH, prot 2.0/HD 15
3 X-27 Clinical GN ND 64/M Prot 1.5/2.0 5
4 XI-15 Clinical GN ND 45/F Prot 2.0/TX 10
5 XI-21 Clinical GN ND 65/M mH, prot 6.0/HD 10
6 XI-27 Clinical GN ND 60/M mH, prot 5.0/HD 12
7 X-8 IgAN IgA IgM C3 55/M mH, prot 1.1/1.0 10
8 XI-28 IgAN IgA IgM C3 50/M mH, prot 1.5/2.0 9
9 X-31 IgAN IgA IgG IgM C3 51/M mH, prot 1.4/1.2 5
10 XII-1 IgAN IgA IgM 38/M mH, prot 1.3/1.3 8
11 XI-8 Mes. Prol. GN IgM C3 60/M prot 1.6/1.8 10
12 XII-3 Mes. Prol. GN IgM 28/M prot 1.0/1.4 8
13 X-4 FSGS IgM, C3 50/M NS 1.1/1.0 10
14 X-6 FSGS IgM 45/M NS 1.0/1.0 13
15 XII-10 FSGS IgM,IgG 42/F NS 0.8/0.9 15
aPatients members of both San Colombano and Collio pedigrees.
Clinical GN=clinical glomerulonephritis; F=female; FSGS=focal segmental glomerular sclerosis; HD=hemodyalisis; IgAN=IgA Nephropathy; M=male; Mes. Prol. GN=mesangial
proliferative glomerulonephritis; Membranous N=membranous nephropathy; MH=macroscopic hematuria; mH=microscopic hematuria; ND=not done; NS=nephrotic
syndrome; PD=peritoneal dyalisis; prot=proteinuria; sCr=serum creatinine; TX=renal transplantation.
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and two with clinical glomerulonephritis. Three affected
siblings and three parent–child pairs were observed.
Pedigree no. 2 (Figure 2). Pedigree no. 2 included eight
patients native of Collio with common ancestors from 1700.
The kindred included two IgAN; one mesangial proliferative
glomerulonephritis without IgA deposits; one FSGS; and four
clinical glomerulonephritis. The patients VIII-12 and VIII-15
were also members of Pedigree no. 1 shown in Figure 2. One
affected sibling pair was identified.
Pedigree no. 3 (Figure 2). Pedigree no. 3 included 15
patients connected by kinship to one large pedigree (12
generations) with common ancestors from 1630. Fourteen
patients were native of Bovegno. One patient was born in
Pezzaze to an emigrant father (X-31). This kindred included
three IgAN; three mesangial proliferative glomerulonephritis
without IgA deposits; three FSGS; and six clinical glomerulo-
nephritis. Three pairs of affected siblings were identified.
Molecular study
We genotyped 26 unlinked tri- and tetranucleotide markers
to compare population structure among the three groups:
Valtrompia cases, Valtrompia controls, and Brescia controls.
Initial analysis of genotypic distribution by exacts tests
revealed one marker (D11S2363), which was out of Hard-
y–Weinberg equilibrium among all three populations; this
locus was therefore eliminated from subsequent analysis.
After elimination of this marker, only one locus (D7S1802)
violated Hardy–Weinberg equilibrium at Po0.01 among
Pedigree 1. San Colombano
I
II
III
IV
V
VI
VII
VIII
IX
I
II
III
IV
V
VI
VII
VIII
IX
X
XI
XII
XIII
I
II
III
IV
V
VI
VII
VIII
IX
X
XI
XII
XIII
XIV
AD 1700
AD 1700
IgA nephropathy
Membranous nephropathy
FSGS
Phenotype unknown
Unaffected
Deceased
Clinical GN
Mesangial GN without 
IgA deposits
AD 1630
AD 1730
AD 1730
AD 1570
Pedigree 2. Collio
Pedigree 3. Bovegno
4 14
15
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18 2021
22 25 28
33 35 37 38
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46
34
1
176 9
1
1
1 3
4 6 7 8 10
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18
Figure 2 | Pedigrees of patients with primary glomerulonephritis connected by close kinship showing common ancestors for the
villages of San Colombano, Collio, and Bovegno. Patients XII-22 and XI-38 of the San Colombano pedigree are also member of the Collio
pedigree, where they are represented as VIII-12 and VIII-15, respectively.
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Valtrompia cases, but not in the overall sample. Given the
number of loci and subgroups tested, this was not considered
to be significant. Comparison of marker characteristics
between the three populations revealed significantly lower
marker heterozygosity and a trend towards lower allele
numbers in Valtrompia populations (Table 2). Comparison
of allele frequencies at individual markers (likelihood ratio
testing) also revealed significant differences (at Po0.05) in
10/25 markers between both Valtrompia populations vs
Brescia controls, whereas only two markers showed sig-
nificant differences in allele frequency between Valtrompia
cases and controls. As single-locus comparisons of multi-
allelic markers across multiple populations pose significant
multiple testing issues, we also tested population differentia-
tion using GENEPOP, which implements a single global
statistic, which compares allelic and genotypic distribution
between samples. These calculations demonstrated significant
differences in allelic and genotypic distributions in compar-
ison of Valtrompia cases vs Brescia controls (P¼ 0.001) or
Valtrompia controls vs Brescia controls (P¼ 0.0002), but not
between Valtrompia cases vs Valtrompia controls (P¼ 0.1).
These data provide statistically significant evidence of
differentiation among the populations tested. Finally, we
calculated the FIS statistic, which is a measure of inbreeding,
among each population (range 1 to þ 1 with higher values
indicative of inbreeding).22 Consistent with the genealogic
data, we observed higher average FIS values among Valtrom-
pia populations compared to Brescia (Po0.05; Table 2).
Taken together, these data provide molecular evidence
supporting the genealogic and historical data showing that
the Valtrompia population is derived from a more limited set
of founders, resulting in lower genetic diversity and increased
inbreeding.
In secondary analyses, we observed no differences in allele
frequencies between mesangial proliferative GN (with or
without IgA deposits) vs other forms of GN and vs
Valtrompia controls. This analysis is limited by the small
number of individual in subgroups, but nevertheless supports
the notion that these patients belong to the same population
group.
DISCUSSION
In this study, we describe the ascertainment of three extended
kindreds, originating from the same isolated region, that
demonstrate several cases of primary glomerulonephritis.
Multiple lines of evidence indicate that the development of
primary glomerulonephritis in this population has a strong
genetic component. Epidemiological investigation did not
reveal a common environmental exposure. No clustering of
cases of glomerulonephritis in epidemic patterns was noted
nor was the temporal pattern of disease consistent with a
single exposure. The frequency of disease in the three villages
was significantly greater than in the population living in the
two nearby villages of Tavernole and Pezzaze, in spite of the
great environmental homogeneity.
The presence of multiple affected first-degree relatives
further favors strong genetic determination, but the patterns
of inheritance is not easily discernable. Among Mendelian
inheritance, autosomal dominant transmission with low
penetrance seems most likely, as three instances of parent–-
child transmission were documented; the parent–offspring
transmission also argue against autosomal recessive inheri-
tance. A marked male predominance was identified, but
male-to-male transmission observed in one instance is not
consistent with X-linked inheritance. Altogether, the ob-
served pattern is most compatible with multifactorial
determination or dominant inheritance of a single locus
with large effect but very low penetrance; this latter pattern
would be consistent with the mode of inheritance described
for familial IgAN and related disorders. Moreover, the
genealogic investigation indicated a limited number of
ancestors with the birthplaces of patients and those of their
ancestors clustering in the extreme northern portion of
Valtrompia valley. These data are in agreement with the
history of reduced population admixture in the extreme
northern Valtrompia population for last centuries, suggesting
the existence of a founder effect and transmission of common
susceptibility allele(s) from one or several common ancestors
to patients with primary glomerulonephritis. Genealogical
reconstructions were confirmed and reinforced by the genetic
analysis that showed lower marker heterozygosity and FIS
values in Valtrompia compared to the Brescia populations,
demonstrating that the Valtrompia population constitutes a
population isolate. There were no differences in allele
frequencies and FIS values between Valtrompia cases and
controls (which were recruited from the villages as the cases).
We therefore expect that Valtrompia cases and controls will
display significant differences in allele frequencies at disease
susceptibility loci but not at neutral, unlinked loci in the
genome.
Different forms of primary glomerulonephritis aggregated
in our pedigrees. The predominant biopsy pattern was that of
Table 2 | Populations genetics parameters among the three populations
Valtrompia cases Valtrompia controls Brescia controls All
N subjects 25 35 35 95
Loci in HW 24 25 25 25
No. of alleles observed 6.671.8 6.671.4 7.272.2 8.472.2
Heterozygosity 0.6970.01* 0.6970.02* 0.7370.02 0.7170.03
FIS 0.05870.13
y 0.06170.1y 070.09 —
*Po0.001 vs Brescia controls.
yPo0.05 vs Brescia controls.
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mesangial proliferative glomerulonephritis, IgAN being the
most frequent form. In addition to relatives with clinical
glomerulonephritis, other types of primary glomerulo-
nephritis, such as FSGS and membranous nephropathy, were
found. Among patients with mesangial proliferative glomer-
ulonephritis, different immunofluorescence findings were
found, some being IgA positive and some IgA negative. These
variations in immunofluorescence findings segregated not
only in the large pedigrees but also within two nuclear
families. Moreover, in a patient mesangial IgA deposits were
detected only in a second renal biopsy. Clinical onset of IgAN
preceding the detection of IgA deposits has already been
reported;20 moreover, resolution of IgA deposits has also
been described in patients with longstanding clinical remis-
sion.23 It is unlikely that the high number of our patients
with mesangial proliferative glomerulonephritis without IgA
deposits could be explained by a late appearance or
disappearance of IgA. Finally, mesangial proliferative glo-
merulonephritis, with or without IgA, showed a similar renal
phenotype, characterized by hematuria and/or non-nephrotic
proteinuria. Thus, from a clinical point of view and in
classification for genetic studies, a separation of mesangial
proliferative glomerulonephritis in two distinct entities on
the basis of the presence or absence of IgA seems
unwarranted.
These considerations enable us to include all biopsies with
mesangial proliferation in a single disease category of
mesangial proliferative glomerulonephritis, regardless of the
presence of IgA deposits. A broader concept of mesangial
disease, not rigidly defined by immunoglobulin subtype
deposition, might represent a unifying hypothesis for IgA-
positive and IgA-negative mesangial proliferative glomerulo-
nephritis observed in our families. The co-segregation of
IgAN with other forms of mesangial proliferative glomer-
ulonephritis has already been described in extended kindred
from isolated ethnic groups. Hoy et al.12 observed high rates
of mesangial proliferative glomerulonephritis in an Indian
community from New Mexico; mesangial IgA was present in
most but not all biopsies. O’Connell et al.11 investigated an
Australian Aboriginal family with a high incidence of renal
disease; IgAN was the most common but not the only
glomerular disease. Ten years ago, we described three
extended pedigrees from Valsaviore valley, another small
mountain valley not so far from Valtrompia valley (see
Figure 1), comprising 39 cases of primary glomerulo-
nephritis. IgAN was the most frequent form; however, other
forms of mesangiopathic disease were also present.13 The
aggregation with membranous nephropathy and FSGS with
nephrotic syndrome is at first difficult to reconcile with
mesangial proliferative glomerulonephritis based on the
traditional histopathologic classification of glomerular dis-
orders. We could therefore hypothesize that these forms of
glomerulonephritis represent chance findings in our pedi-
grees. However, familial aggregation of membranous nephro-
pathy and FSGS with IgAN were reported previously.13,14
Hence, we should also consider that the presence of diverse
nephropathies in families originating from a homogeneous
ethnic group might truly represent a common pathogenic
link underlying these traits.
These considerations are not biologically implausible and
have support both in clinical practice and genetic investiga-
tions. For example, lupus nephritis can manifest as mesangial
proliferative glomerulonephritis, membranous nephropathy
or both; mutations in the BRCA1 and BRCA2 genes can
result in familial predisposition to various forms of cancer.
Conversely, broad classification of stroke phenotypes enabled
the mapping and identification of the phosphodiesterase 4D
gene.24 Thus, aggregation of these broad renal phenotypes in
Valtrompia represents an intriguing and testable hypothesis
in favor of a common pathogenic mechanism underlying
these traits.
In summary, we have reported familial clustering of
primary glomerulonephritis in an isolated Italian population,
confirming the role of genetic factors in pathogenesis of the
disease. Genetic analysis of ethnic isolates represents the most
promising approach in the identification of genes involved in
the pathogenesis of complex traits.19,25 Although a priori one
does not know whether findings will apply to the general
population, genes identified in genetic isolates can identify
pathways that are relevant to disease in the general
population. Thus, such population is ideally suited for
studying the genetic contribution to sporadic disease as they
would enable the identification of single gene with large effect
but very low penetrance.16 Such approach has been
successfully utilized to identify genes underlying complex
traits, particularly in populations from Icelandic or Sardinia.
This study thus provides the unique opportunity to apply
similar approach to unravel the genetics of primary
glomerulonephritis, in a small isolated population. For these
considerations, we will undertake in our families analysis of
linkage, successfully applied to a familial IgAN.14 We expect
that molecular study will offer the possibility to shed light on
the genetic background of the different glomerular disorders
found in our population.
MATERIALS AND METHODS
Valtrompia population The extreme northern portion of the
Valtrompia valley (district of Brescia, Northern Italy) comprises
three mountain villages characterized by high frequency of primary
glomerulonephritis: Collio (1500 inhabitants), San Colombano (900
inhabitants), and Bovegno (2300 inhabitants) (Figure 1). The
extreme northern Valtrompia population is characterized by low
number of founders and high endogamy. The first historical
mention of the villages dates back to the XV century. Through the
centuries, the villages have been crossed by diverse calamities that
have dramatically decimated the population. Geographical and
cultural isolation have generated a great deal of homogeneity in
lifestyle and eating habits. In order to verify that the high frequency
of primary glomerulonephritis was confined to Collio, San
Colombano, and Bovegno, and to ascertain a possible causative
role of environmental factors, two nearby villages, Pezzaze (1200
inhabitants) and Tavernole (1330 inhabitants), with similar culture,
diet, and occupation, were included in the study. Overall, the
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population of the five villages over 18 years old suitable for the
urinary screening was 6 200 people (M/F ratio 1.06:1).
Establishment of the Valtrompia study
At Division of Nephrology of Brescia, primary referral center for
Valtrompia valley, we diagnosed several cases of primary glomer-
ulonephritis in patients born in extreme northern Valtrompia valley.
This led us to propose a community network for renal research on
primary glomerulonephritis, including Division of Nephrology,
National Health Service, and municipal councils of the villages. The
collaboration culminated in the establishment of the Valtrompia
Study.
Patients’ charts review
We first searched the computerized archive of the Division of
Nephrology for cases of primary glomerulonephritis diagnosed
between 1971 and 1998 in patients originating from the five villages
from Valtrompia valley. Patient charts of the identified subjects were
reviewed for clinical findings and renal histology.
Community urine screening
In order to identify asymptomatic patients with glomerular disease,
a community screening program was planned in 1998. Dipstick
urinalysis (Ames) was offered in loco by our staff to the inhabitants
of the five villages. Individuals with urinary abnormalities, defined
by positive reading (41þ ) for blood and/or protein confirmed
in three subsequent tests, underwent further assessment. In the
presence of normal renal imaging, individuals with persistent
urinary abnormalities were offered a renal biopsy. Individuals with
secondary renal disease were not included in the study.
Diagnostic criteria
Diagnosis of IgAN, FSGS, and membranous nephropathy were made
on the basis of accepted pathologic and clinical criteria. A
morphologic category of mesangial proliferative glomerulonephritis
without IgA deposits was defined, based on the following criteria:
(1) Light microscopy: Mesangial proliferation and/or expansion,
with a variable degree of glomerular sclerosis.
(2) Immunofluorescence study: Mesangial deposits of IgM, and/or
IgG and/or C3, in absence of IgA.
(3) Absence of nephrotic syndrome: Clinical glomerulonephritis was
indicated for patients not subjected to renal biopsy who had
persistent urinary abnormalities, in the absence of secondary
causes. Anatomical abnormality or nephrolithiasis were
excluded by ultrasonography or urography.
Genealogic investigation
Details of births, deaths, marriages, and people’s origins have been
preserved since 1570 in the parochial Quinque Libri. The
genealogical research was conducted for each village in order to
link to a common ancestor the patients with glomerular disease.
All data were transferred into databases, allowing the creation of
genealogical trees for each village comprising all affected people.
Cyrillic software, version 2.1 (Cherwell Scientific, Oxford, UK)
was used.
Molecular study
To further characterize the ancestry in the populations studied at the
molecular level, we use genotyped 26 unlinked microsatellite
markers distributed across 18 autosomes. For this analysis, we
compared 25 affected individuals from Valtrompia to 35 unrelated
controls recruited from the three Valtrompia villages with high
incidence of glomerulonephritis (San Colombano, Bovegno, or
Collio). Subjects were selected as Valtrompia controls if they and
both parents were born in San Colombano, Bovegno, or Collio, were
age 440, and had no personal or family history of nephropathy in
first- or second-degree relatives. The Valtrompia population was
further compared to 35 unrelated controls from the town of Brescia,
which is the nearest large city located 40 km from the villages we
studied. The criteria for selection of Brescia controls included place
of Birth in Brescia, age 440 years, and the absence of personal or
family history of nephropathy in first- or second-degree relatives.
All individuals participating in the study gave informed consent
for blood sample collection according to The Declaration of
Helsinki Principles and approved by the local Ethic Committee.
Total genomic DNA was isolated from peripheral white blood
cells of the patients and relatives using standard procedures. Markers
were selected from a genome-wide panel of tri- and tetranucleotide
microsatellite used to characterize ancestry in several worldwide
populations. Fluorescent dye-labeled primers were used to direct
polymerase chain reaction at microsatellite loci. Polymerase chain
reaction products were resolved on a capillary sequencer (Spectru-
Medix LLC, State College, PA, USA), and genotypes were scored
using the GenoSpectrumV220 software (SpectruMedix LLC, State
College, PA, USA).
We used the population genetics programs GENEPOP26 (web
address http://wbiomed.curtin.edu.au/genepop/index.html) and
FSTAT27 to characterize the structure of the populations studied. This
program provides tools for basic evaluation allele distribution patterns
and also implements standard global statistics used to evaluate
population differentiation using allelic and genotypic frequencies.
These programs provide an unbiased estimate of the P-values using
a Markov chain method: the P-values reported here are based on
running 1000 batches of 10 000 iterations for each statistic reported.
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Appendix A
Loci tested Repeat Heterozygosity
D3S2432 TETRA 0.76
D3S3045 TETRA 0.735
D4S2431 TETRA 0.647
D4S2632 TETRA 0.761
D5S1505 TETRA 0.899
D5S2505 TETRA 0.804
D6S1051 TETRA 0.682
D6S1277 TETRA 0.709
D7S1802 TETRA 0.752
D7S2202 TETRA 0.8
D8S1128 TETRA 0.707
D9S1121 TETRA 0.807
D9S930 TETRA 0.508
D10S1425 TETRA 0.678
D10S1435 TETRA 0.583
D11S2362 TETRA 0.744
D11S4463 TETRA 0.747
D12S2078 TETRA 0.66
D12S373 TETRA 0.775
D13S779 TRI 0.703
D13S787 TETRA 0.629
D15S816 TETRA 0.642
D16S2616 TRI 0.709
D17S1301 TETRA 0.608
D18ATA82B02N TRI 0.716
D19S1034 TETRA 0.718
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